Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
33 Doxorubicin (DOX) is a powerful cytotoxic drug, but its use is limited because of dose-dependent toxicity, including nephropathy
For the bigger picture on where GHK-Cu fits, read our peptide therapy guide and the rising popularity of peptide therapy in India
Common Side Effects Injection site reactions Headache Flushing Mild fluid retention Metabolic and Hormonal Considerations Potential alterations in glucose metabolism Elevated IGF-1 levels Theoretical risk of promoting tumor growth in predisposed individuals Key Limitation Most safety data comes from: Pediatric GH deficiency populations Adults with endocrine disorders There is limited long-term data in healthy, high-performing athletes
Australia's TGA has scheduled BPC-157 as Schedule 9 (Prohibited Substance) effective July 1, 2026
Hair regrowth, peptide therapy, GLP-1 weight loss, and longevity care are available to all patients nationwide
